Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avi Mex S A De C V LabfiledCriticalAvi Mex S A De C V Lab
Priority to MX2010003505ApriorityCriticalpatent/MX2010003505A/en
Publication of MX2010003505ApublicationCriticalpatent/MX2010003505A/en
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
A vaccine is described, comprising an inactivated viral vector having inserted an exogenous nucleotide sequence coding for a disease of concern; and, a pharmaceutically acceptable vehicle, adjuvant or excipient, which provides due protection against the disease of concern by using a viral vector titer similar to that required for an active-virus vaccine based on the same viral vector. Mainly, viral vectors of paramixovirus or adenovirus are described.
"attenuated recombinant parvovirus, vaccine for the protection of animals against parvovirus infection, method for obtaining a recombinant parvovirus, and use of a vaccine."